Next Article in Journal
Effects of Different Pollination Methods on Oilseed Rape (Brassica napus) Plant Growth Traits and Rapeseed Yields
Next Article in Special Issue
The Cholesterol-Modulating Effect of the New Herbal Medicinal Recipe from Yellow Vine (Coscinium fenestratum (Goetgh.)), Ginger (Zingiber officinale Roscoe.), and Safflower (Carthamus tinctorius L.) on Suppressing PCSK9 Expression to Upregulate LDLR Expression in HepG2 Cells
Previous Article in Journal
Effects of Pedicularis kansuensis Expansion on Plant Community Characteristics and Soil Nutrients in an Alpine Grassland
Previous Article in Special Issue
Anti-Biofilm and Associated Anti-Virulence Activities of Selected Phytochemical Compounds against Klebsiella pneumoniae
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

A Complete Review of Mexican Plants with Teratogenic Effects

by
Germán Chamorro-Cevallos
1,
María Angélica Mojica-Villegas
1,
Yuliana García-Martínez
2,
Salud Pérez-Gutiérrez
3,
Eduardo Madrigal-Santillán
4,
Nancy Vargas-Mendoza
4,
José A. Morales-González
4 and
José Melesio Cristóbal-Luna
1,*
1
Laboratorio de Toxicología Preclínica, Departamento de Farmacia, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Av. Wilfrido Massieu 399, Col. Nueva Industrial Vallejo, Del. Gustavo A. Madero, Ciudad de México 07738, Mexico
2
Laboratorio de Neurofisiología, Departamento de Fisiología “Mauricio Russek”, Instituto Politécnico Nacional, Escuela Nacional de Ciencias Biológicas, Av. Wilfrido Massieu 399, Col. Nueva Industrial Vallejo, Del. Gustavo A. Madero, Ciudad de México 07738, Mexico
3
Departamento de Sistemas Biológicos, Universidad Autónoma Metropolitana-Xochimilco, Calzada del Hueso 1100, Del. Coyoacán, Ciudad de México 04960, Mexico
4
Laboratorio de Medicina de Conservación, Escuela Superior de Medicina, Instituto Politécnico Nacional, Plan de San Luis y Díaz Mirón, Col. Casco de Santo Tomás, Del. Miguel Hidalgo, Ciudad de México 11340, Mexico
*
Author to whom correspondence should be addressed.
Plants 2022, 11(13), 1675; https://doi.org/10.3390/plants11131675
Submission received: 3 June 2022 / Revised: 20 June 2022 / Accepted: 21 June 2022 / Published: 24 June 2022
(This article belongs to the Special Issue Phytochemicals Beneficial to Human Health)

Abstract

:
In Mexico, the use of medicinal plants is the first alternative to treat the diseases of the most economically vulnerable population. Therefore, this review offers a list of Mexican plants (native and introduced) with teratogenic effects and describes their main alterations, teratogenic compounds, and the models and doses used. Our results identified 63 species with teratogenic effects (19 native) and the main alterations that were found in the nervous system and axial skeleton, induced by compounds such as alkaloids, terpenes, and flavonoids. Additionally, a group of hallucinogenic plants rich in alkaloids employed by indigenous groups without teratogenic studies were identified. Our conclusion shows that several of the identified species are employed in Mexican traditional medicine and that the teratogenic species most distributed in Mexico are Astragalus mollissimus, Astragalus lentiginosus, and Lupinus formosus. Considering the total number of plants in Mexico (≈29,000 total vascular plants), to date, existing research in the area shows that Mexican plants with teratogenic effects represent ≈0.22% of the total species of these in the country. This indicates a clear need to intensify the evaluation of the teratogenic effect of Mexican plants.

1. Introduction

Since ancient times, humans have used the elements in their environment to satisfy their basic needs. Such is the case of plants, which for millennia have been utilized by humans to produce food, shelter, clothing, footwear, dyes and stains, means of transport, fertilizers, fragrances, cosmetics, as fuel and, of course, to alleviate their diseases [1,2]. There is solid evidence that plants have been cultivated for their biological effects for over 60,000 years [3], with the earliest written records on the preparation of herbal remedies and their biological effects being found in Sumerian tablets [4] and in Egyptian, Indian, and Chinese inscriptions aged approximately 5000 years, such as Ebers papyrus [5], Rigveda texts [6], and the book Pen T’Sao [7], respectively.
In places such as Greece and Central Asia, these first records have been found in more recent times, that is, approximately 2500 years ago [8], while in Mexico it is possible to find records of the use of plants with medicinal purposes (by the Olmec, Mayan, Mixtec, and Aztec), such as the Códice De la Cruz Badiano or the Libellus de Medicinalibus Indorum Herbis [9]. It is difficult to establish a concise period for the first records of their medicinal use, because the majority of Mesoamerican literature, in the form of códices, were burned in the years after the Conquest by Spanish missionaries [10]. In this regard, according to archaeological records, the process of domestication and the use of plants in Mesoamerica began about 7000 and 5000 years ago, respectively [11]. The latter can provide us with an idea of the important role that plants have played as a means of health in the native societies of the current territory of México.

1.1. From Plants to Drugs

According to the significance that Greece, the cradle of philosophical thought and Western civilization, has held in the sciences and arts, it should not come as a surprise to us that the Greeks were the fathers of Medicine, Botany, and Pharmacology (Hippocrates, Theophrastus, and Pedanius Dioscorides, respectively), who laid the foundations of the therapeutic value of medicinal plants through detailed compilations of the knowledge of medicinal plants during their respective times and in their respective regions [12,13,14], as well as that herbal medicine is denominated phytotherapy, a compound word formed by the Latin prefix phyto “plant”, and the Latin word therapia, “to treat medically”, in the study of the use of extracts of natural origin as medicines [15].
With the fall of the Western Roman Empire (476 AD), there began a period of time that stretched from the V to the XV century, called the “Middle Ages” or the “Dark Ages”, which involved a notable lag in the development of the sciences [16], despite that knowledge on the use of medicinal plants (and many others) survived during being confined for several centuries inside the walls of monasteries in countries such as England, Ireland, France, and Germany [17], among others. The Arab people were responsible for the preservation of a great part of Greco–Roman knowledge (along with that of the Chinese and the Indians, mainly in terms of plants), and later with the establishment of the first private pharmacies in Baghdad, Irak, at the end of the 8th century [18,19]. Later, the Persian pharmacist and poet Avicena (980–1037 AD) contributed to the dissemination of the knowledge of therapeutic plants with his work “Canon Medicinae”, considered the latest translation of all Greco–Roman Medicine [1] and the starting point for the development of medicinal-plant texts throughout Europe, such as “The Corpus of Simples” by Ibn al-Baitar, or the Florentine “Nuovo Receptario Composito”, which, alongside other manuscripts in England (1518), laid out the concept of “pure compounds” and promoted their development; a century later, these manuscripts would comprise the basis of the emergence of the first pharmacopoeia (First London Pharmacopoeia) [20]. Deriving from this idea, the first natural product to be marketed as isolated and pure was morphine, by Merck in 1826; while the first semi-synthetic medicine based on a natural product was aspirin by Bayer in 1899 [21].
The health needs of our increasing population have intensified the interest in developing more effective chemically synthesized compounds. In this context, since 1910, there was the “magic bullet” (Salvarsan or compound 606) by the German bacteriologist Paul Ehrlich [22], continuing all the way to modern times with the development of drugs used for chronic obstructive pulmonary disease, such as umeclidinium bromide [23]. Despite the good results obtained with chemical synthesis, the therapeutic potential of medicinal plants was not lost from sight. From plants such as meadowsweet (Spiraea ulmaria), poppy (Papaver somniferum), foxglove (Digitalis purpurea), and barbasco (Lonchocarpus utilis), drugs as remarkable as acetylsalicylic acid [24], morphine [25], digoxin [26], and diosgenin [27], respectively, have been obtained. Currently, this approach has become diversified thanks to the boom in novel processes for the extraction and identification of organic compounds, but mainly due to the increasing use of traditional medicine, which has been the starting point for information obtained throughout scientific research for the development of molecules that, under different conditions, would have been difficult or virtually impossible to conceive. In this regard, nature arises and is constituted, with chemical synthesis [28] and with biotechnology [29], one of the three main ways to obtain biologically active molecules today [30]. This said fact can be observed as reflected in the growing number of studies during the last decades that have provided valuable information to this scientific field, confirming the molecules present in the structures of numerous plants that possess a biological effect against diseases. However, in addition to the development of the knowledge of plant curative properties, the misconception of the safety of natural products has become a health problem that can be confirmed in several epidemiological and experimental assays.

1.2. Mexican Plants

Worldwide, Mexico has one of the richest diversities of plants composed of native and introduced species from various parts of the planet [31] that, together with their cultural wealth, constitute Mexican Traditional Medicine. In general terms, the concept of traditional medicine refers to a conventional denomination adopted by researchers to refer to empirical medical systems that are organized and based on various cultures of the world [32]. Thus, traditional medicine is made up of three main types according to the source of the remedy: that obtained from animal products; that of processed minerals, and Botany [33]. With regard to the latter, it is difficult to accurately determine the number of families, genera, or species of existing Mexican plants. Some reports estimate that Mexico has approximately 22,351 species of vascular plants (native and introduced) and calculate that at least 6500 species must be added to this calculation [34,35]. Of this total number (≈29,000 total vascular plants), it is suggested that between 3000 and 5000 plants are currently utilized with medicinal purposes in the country [36].

The Teratogenic Effects of Mexican Plants

During pregnancy, the organogenesis phase is the most critical period for generating birth defects, because it is at this time that the differentiation and specialization of tissues, structures, organs, and systems in the conceptus begin, with the grouping of cells in early patterns directed by gene expression toward specific sites in an organ [37]. Thus, during this period, it is most likely (but not exclusively so) that there occurs a multifactorial process known as teratogenesis. The latter, as a result of multiple interactions between environmental (physical, chemical, biological, and maternal diseases, clinical states, etc.) and endogenous (genetic background of the mother and the embryo/fetus) factors, can produce a wide range of congenital deformities in the developing fetus or in the newborn [38]. Although the mechanisms by which this process occurs are varied, the main ones include oxidative stress, folate antagonism, vascular disruption, neural crest cell disruption, endocrine disruption, and specific receptor- or enzyme-mediated actions, among others [39]. Therefore, the severity and type of alterations will depend, among other things, on the time of the interaction of the teratogenic agent with the embryo/fetus, as well as on the mechanism(s) involved in the disruptive process.
The wide diversity of plants in Mexico allows some of these to be used by humans to alleviate their diseases or as food [40,41], even for livestock. In Mexico, as in other developing countries, the use of medicinal plants remains the first health care available in many rural areas to alleviate the diseases of the most economically vulnerable population, without social security [42,43], as a substantially less expensive and affordable alternative to conventional therapies. Unfortunately, in this practice, quality is generally unproven and is solely based on the population’s beliefs. In contrast, insufficient attention is paid to their possible toxicity (unlike what happens with drugs), with the belief espoused for generations, e.g., “the natural remedy” is totally safe, without taking into consideration that plants could contain toxic compounds. Thus, although plants are undeniably an important source of health for vulnerable persons, it is important to make it known to the general population that “natural is not always safe”.
The data provided by several investigations demonstrate than an important number of herbs and herbal products have been implicated in poisoning [44], health problems [45], and alterations in embryonic/fetal development in humans [46] and animals [47]. This latter toxic effect of plants comprises an important problem worldwide, not only for public health, where birth defects are one of the main preventable causes of morbidity, mortality, and childhood disability [48], but also in the economic sector, since in different parts of the world, the consumption of teratogenic plants by pregnant females produces a wide variety of congenital anomalies in livestock, generating, in this manner, considerable losses of capital for companies and local ranchers [49].
This work provides an updated catalog of native and introduced vascular plants in Mexico with a teratogenic effect, in order to describe the main birth defects produced by these in different models, as well as their implications during pregnancy. In addition, we underscore those plants that should be avoided during the critical period of pregnancy because of their harmful effects on the developing embryo/fetus (abortifacient and/or teratogenic potential). Additionally, this review seeks to serve as the basis for generating novel research projects, new questions, a better understanding of the Mexican flora, and as a promoter of the responsible and safe use of medicinal plants. For example, in Mexico, there are a considerable number of plants termed “sacred” that are employed with religious purposes due to their hallucinogenic effects, plants that are rich in alkaloids (these will be discussed later), plants without (to our knowledge) studies that support their safety or that warn of their toxicity during pregnancy and that are currently used without any type of regulation by ethnic populations.

2. Methodology

A scoping review of Mexican plants with a teratogenic effect was conducted in the principal academic research databases (DOAJ, PubMed, ScienceDirect, Scopus, Web of Sciences and Springer) and academic search engines (Google Scholar, Science.gov, and Microsoft Academic). The search was carried out in the first instance by faceting the main ideas that make up our research, which were later condensed into keywords and which in turn were utilized in different combinations to feed the academic search engines and databases in order to identify potentially relevant studies for their inclusion in our review as follows: “teratogenesis, teratogen, teratogenic effect, teratogenic plants, plant extracts, sacred plants, Mexican plants, herbal, herbal medicine, medicinal plants, traditional Mexican medicine, natural products, phytotherapy, pregnancy, birth defects, and congenital malformations”.
To achieve this goal, we adopted as inclusion criteria, articles, papers, books, book chapters, reports, patents, and theses on plants native to or introduced into Mexico with proven teratogenic effects, published during the last 72 years (1950–2022) and, as exclusion criteria, studies that address another type of toxicity not related to our main objective, information on compounds or molecules other than those obtained from plants, information from unreliable sources, information from years prior to 1950, information that does not refer to the keywords raised, repeated teratogenic plants previously found, and works on teratogenic plants that are not present in Mexico. To perform this selection, we compared the plants in the studies found with the checklist of the native vascular plants of Mexico [34] and with the databases of the Invasive Species Compendium [50], the Herbario Virtual of the Comisión Nacional para el Conocimiento y Uso de la Biodiversidad [51], the platform iNaturalist (citizen science social network) [52], and the Red de Herbarios del Noroeste de México [53], to differentiate between native plants, plants introduced from other countries, and plants that do not present in Mexico.
Please note that this review was focused only on the variety of plants with teratogenic effects. Therefore, no information is included on the number of investigations conducted on the same plant by different authors, with different animal species, doses, or any other different variable.

3. Results

3.1. Teratogenic Plants from Mexico

In this review, 63 species of Mexican plants with teratogenic effects distributed in 56 genera were identified (Table 1). Compared to the enormous number of plant species in Mexico, this figure scarcely represents ≈0.21% of the total number of species in the country. In the studies consulted, the main plant parts employed were leaves, followed by seeds, fruits, roots, flowers, and bark. Evidently, this fact depended on the amount and type of the compound suspected as the teratogenic agent in the studied species. For example, alkaloids are mainly found in leaves, barks and, to a lesser extent, in roots [54], and cyanides are often found in rhizomes and, at lesser amounts, in fruits and seeds [55]. However, essential oils (a complex mixture of fatty acids, aldehydes, esters, phenols, ketones, alcohols, nitrogen, and Sulphur) are isolated from various plant structures, such as peel, stem, leaves, flowers, roots, and woods [56]. Although the majority of the studies were conducted on livestock, complete plants were administered to pregnant animals through their diet, mixed with food; in laboratory animals such as rats, mice, fish, frogs, and chickens, the majority of the investigations opted to extract the representative compounds of the plant-in-question, utilizing different types of solvents according to the compound that the plants were suspected to obtain; for example, aqueous extracts for flavonoids, alkaloids, steroids, terpenoids, phenols, and terpenes; methanolic extracts for sterols, flavonoids, some alkaloids, and lectins; ethanolic extracts for diterpenes, aldehydes, and polyketides, and organic extracts for lycopene, fatty acids, some alkaloids, sterols, and terpenes. As can be observed, the relative polarity of the solvents employed ranges from the lowest with hexane (0.009) and continues in increasing order with benzene (0.111), methylene chloride (0.309), ethanol (0.654), and methanol (0.762), to the compound with the highest relative polarity: water (1.0). That is, the authors played with the intensity of the interactions of solvents with their molecules-of-interest to extract apolar compounds by applying non-polar solvents, and vice versa [57].
The case of the alkaloids is very interesting because, as bases, they are scarcely soluble in water, but are very soluble in polar (alcohols) and apolar (ether, chloroform, hexane) organic solvents [58] Nevertheless, in the various studies in which they were identified, alkaloids were obtained through aqueous extracts and, in very few cases, by hydroalcoholic or organic extracts. This is most likely because the experiments involved attempted to imitate the way in which the plant is ingested by humans, in the form of teas (aqueous extracts).
The main compounds identified as the cause of the developmental alteration observed in different studies, in descending order, were as follows; alkaloids (22); unknown (20); terpenes (5); flavonoids (3); steroids (3); carbohydrates (2); cyanide (2) M lycopene (2); polyphenols (2); acids (1); aldehydes (1); amino acids (1); β-carotenes (1); fatty acids (1); lactones (1); gingerols (1); lectins (1); peroxides (1); polyketides (1), and sterols (1). It is not surprising that the majority of these investigations found alkaloids to be responsible for the teratogenic effect, as for decades there has been full knowledge that these compounds generate a wide variety of developmental defects in humans and animals [59]. However, due to the large number of studies in which the compound responsible for the teratogenic effect is not mentioned, leads us to think that this is because determining this data was not a priority for the study. It is curious that a wide variety of natural compounds with a low incidence of teratogenic effects was identified as teratogenic compounds. Thus, it is essential to consider these for future studies, as for several of these there are insufficient reports or citations in the literature specifying their teratogenic properties.
Table 1. List of Mexican plants screened for their teratogenicity.
Table 1. List of Mexican plants screened for their teratogenicity.
TeratogenAnimal/Model
PlantUsed PartDosesRoute of
Administration
CompoundMechanismSpeciesStatusMalformationsOriginCitation
Acanthospermum hispidumLeaves, stalk, and seeds; AqExAqEx 10%,
0–600 mg/kg/day
IG, during organogenic periodSesquiterpenoids (terpenoids) and phenolic compounds-Wistar ratsNormalAnomalies in urinary system, palatosquisis, acampsia, ear heterotopic, cranial alterations, micrognathia, gastroschisis, extra ribs.Introduced from Brazil[60]
Acanthus montanusLeaves; Met:MCEx (1:1)1000 mg/kgIG, GD6–15β-sitosterol (sterol)-Wistar ratsNormalEmbryotoxicity, reduction in fetal body weight, crown-rump, tail lengths; reduced ossification of extremities bones.Introduced from Africa[61]
Ageratum conyzoidesLeaves; HAEx (80:20)1000 mg/kgOral, GD17–20Pyrrolizidine alkaloidsOxidative stressWistar ratsNormalDecrease fetal weight.Native of Mexico[62]
Aloe barbadensis millerLeaf; juice3 mL/ratIG, GD4–15--Wistar ratsNormalReduction in fetal body weight, crown rump length, tail length; renal alterations as shrunken tubules, mild degeneration of glomeruli, narrowing of capsular spaces.Introduced from Africa[63]
Alstonia macrophyllaLeaves; EtEx10 mg/miceIG, GD8–15Acetogenins (polyketides), styryl-lactones and alkaloids-ICR miceNormalHead shape angular, reduced elongation in the snout, abnormalities in digits of forelimbs and hindlimbs (separate fully or lack of some digits), altered body shape morphology, dead implants.Introduced from Indonesia[64]
Alstonia scholarisStem bark; HAEx (85:15)480 mg/kgIP, GD11--Swiss albino miceNormalMortality, growth retardation, body length reduction, bent tails, syndactyly, delay in fur development, eye opening, pinna detachment, and vaginal opening, testes descent, ear unfolding.Introduced from India[65]
Artemisia annua L.Leaves; OEx 70 mg/kgIG, GD14–20Artemisinin (sesquiterpene)-Wistar ratsNormalPost-implantation losses.Introduced from Asia[66]
Astragalus lentiginosus (locoweed)Leaves25%Oral, mixed with food during pregnancy--Columbia sheepsNormalAbortion, skeletal malformations (flexure of carpal joint, lateral rotation front legs, hypermobility hock and stifle joint), fetal edema, ascites, fetal hemorrhage, less gross effect on fetal cotyledons.Native of Mexico[67]
Astragalus mollissimus TorrLeaves and stems-Oral, during pregnancySwainsonine alkaloids-Horses, lambs, NormalSkeletal defects, limb contractures.Native of Mexico[68]
Astragalus pubentissimusLeaves and stems-Oral, mixed with food during pregnancySwainsonine alkaloids-Sheep and cattleNormalAbortions, lateral rotation of forelimbs, contracted tendons, anterior flexure, looseness of hock joints, flexure of the carpus, decreased length.Introduced from North America[69]
Azadirachta indicaSeeds oil1.2 mLIG, during whole pregnancy-Oxidative stressSprague Dawley ratsNormalAnophthalmia, enlarged trachea, abnormally shaped sternebrae, macroglossia, exencephaly.Introduced from India[70]
Cajanus cajanLeaves; AqEx0–600 mg/kg/dayIG, during organogenic period--Wistar ratsNormalAnomalies in urinary system, palatosquisis, acampsia, ear heterotopic, cranial alterations, micrognathia, gastroschisis, extra ribs.Introduced from Brazil[71]
Cannabis sativa L. (ganga)Resin4.2 mg/kgIP, GD1–6Cannabinoid alkaloids-Wistar rats; miceNormalHigher rate of resorptions and syndactyly, encephalocele, phocomelia; decrease in fetal weight and size; dental asymmetry.Introduced from Asia[72,73]
Carthamus tinctoriusFlowers; AqEx1.2 mg/kgIG, GD0–8-CytotoxicityAlbino miceNormalChanges in external, internal and longitudinal diameters, open neuropore, changes in cellular orientation and cellular degeneration, disconnected lateral folds.Introduced from Mediterranean[74]
Caryocar brasilienseFruits (dried pulp); Oex1000 mg/kgIG, GD6–15Oleic acid (fatty acid), β-carotene and lycopeneHigh antioxidant capacity, probablyWistar ratsNormalBruises, developmental delay, distended abdomen, incomplete ossification, vertebra in dumbbell, sternebra misaligned or bipartite, ribs wavy or supernumerary, change in shape of bones, absent sternebra or ribs, shortening of forelimbs and hindlimbs.Introduced from Brazil[75]
Cinnamomum zeylanicumLeaves; AqEx, Cex70 mg/kgIP, throughout pregnancy--Wistar ratsNormalFetal resorption.Introduced from South Asia[71]
Conium maculatumLeaves, fruits2 and 1 mL/dayIG; GD25–35 sheep and GD55–75 cowsPiperidine alkaloids (coniine, N-methyl-coniine, conhydrine, pseudoconhydrine, γ-coniceine)Restricted fetal movement (sedative or anesthetic effect of alkaloids)Columbia sheep, cowsNormalCleft palate, under-extension of carpals and pastern joints, limb and spinal deformities.Introduced from Europe[76,77]
Cortex cinnamom L. (Lauraceae)Cortex; EtEx0.5 mmol/embryoIn ovoCinnamaldehyde (aldehyde)-ChickWhole embryo cultureMalformations and lethality.Introduced from India[78]
Croton megalocarpusLeaves; MetEx1000 mg/kgIG, GD6–16-Interference with the mechanisms involved in the production or removal of amniotic fluidSwiss albino miceNormalFetal resorption, microcephaly, polyhydramnios.Introduced from Africa[79]
Curcuma longaRhizome; MetEx125.0 μg/mLIn medium, 6 hpfCatechin, epicatechin, and naringenin (flavonoids)Weakened or damaged embryo protective layer (chorion)Zebra fishWhole embryo cultureBody deformities of larvae, kink tail, bend trunk, enlarged yolk sac edema.Introduced from Southeast Asia[80]
Datura stramonium ---Unknown, possibly alkaloids-PigsNormalCleft palate, contracture-type skeletal defects.Native of Mexico[81]
Derris ellipticaLeaves; AqEx0.50%Culture medium--Zebra fishWhole embryo cultureReduced hatchability, lower heartbeat, delayed formation, undeveloped head and tail region, coagulation and death of embryos.Introduced from India[82]
Descurainia sophiaLeaves10%Oral, mixed with food during first 2 months of pregnancy3-butenyl glucosinolate (glycosides)-GoatsNormalHypothyroidism, absence of hair, goiter, abnormally large birth weights.Introduced from Eurasia[83]
Garcinia kolaSeeds; AqEx200 mg/kgIG, GD1–5Flavonoids-Sprague Dawley ratsNormalDecrease in fetal weight, malformed left upper limb.Introduced from Africa[84]
Ginseng (Spp)Root780–1560 mg/kgIG, throughout pregnancyGinsenoside (steroid glycosides and triterpene saponins)Activation of ginseng saponinsAlbino miceWhole embryo cultureMalformation of sternum, defects in the lumbar vertebrae, bad union of transverse processes with vertebral body.Introduced from China and Korea[85]
Indigofera spicataSeeds; ion-exchange extraction1 mL/100 g (1 mL of extract equals to 10 g seeds)IG, GD13Canavanine (amino acid)Amino acid antagonismSprague Dawley ratsNormalCleft secondary-palate, somatic dwarfism, hepatic toxic change.Introduced from Africa[86]
Ipomoea carneaLeaves; AqEx15.0 mg/kgIG, GD5–21Swainsonine (alkaloid) and caligestinesInhibition of acidic/lysosomal ámannosidase and Golgi mannosidase II; and glicosydasesWistar ratsNormalReduction in ossification centers, kidney symmetry, dilated renal pelvis, hemorrhagic kidney, dilated cerebral ventricle, hemorrhagic cerebrum, hemorrhagic thyroid gland, spongy lung, and embryotoxicity.Native of Mexico[87]
Krameria cytisoides CavLeaves; MetEx1000 mg/kgIG, GD6–15Kramecyne (hexamer of cyclic peroxide monomers)Inhibition of cyclooxygenase 2 and consequent inhibition of prostaglandin synthesis; and ROS imbalance due to an increase in antioxidant enzymes (most likely)Wistar ratsNormalDecrease of fetal length and weight, live fetuses; increase of post-implantation loss; incomplete ossification in cranial vault, pelvis, sternum; asymmetric sternebrae; rudimentary and undulate ribs.Native of Mexico[88]
Lantana camaraLeaves; HAEx (70:30)7 g/kgIG, 14 days prior to mating and over the pregnancy (GD21)--Wistar ratsNormalIncrease of resorption rate and post-implantation loss index, forelimbs poorly ossification, sternebra with incomplete ossification.Native of Mexico[89]
Lavandula angustifoliaLeaves; AqEx15 mg/kgIP, GD3–6Linalool (terpene)-BALB/c miceNormalLimb displacement from symmetry axis, encephalocele, no brain development, scoliosis, hemorrhage, spinal cord protrusion, eye protrusion, lack of limb, ear, eye and exohepatic development.Introduced from Mediterranean[90]
Lawsonia inermisLeaves; AqEx10 mg/kgIP, GD1–7-Decreased levels of progesterone and increased levels of estrogenBALB/c miceNormalAbortion (fetal death).Introduced from Africa[91]
Leucaena leucocephalaLeaves50%Oral, mixed with food during pregnancyMimosine (alkaloid)-GoatsNormalAbortions at different stages of pregnancy, congenital goiter.Native of Mexico[92]
Luffa operculataFruits; AqEx4 mL/kgIG, GD1–9--CD1 miceNormalCleft palate, anencephaly, exophthalmia, exophthalmia, delayed bone development; and decrease in implantation sites, live fetuses, and birth rate.Native of Mexico[93]
Lupinus caudatusLeaves and stems-Oral, mixed with food GD40–70Anagyrine (alkaloid)-CowsNormalMultiple congenital contractures, torticollis, arthrogryposis, kyphosis, rib cage deformities, scoliosis.Introduced from North America[94]
Lupinus formosusWhole plant2.25–3.16 g/kgIG, twice daily GD40–70Ammodendrine, piperidine and quinolizidine alkaloidsRestricted fetal movement (sedative or anesthetic effect of alkaloids)CowsNormalCleft palate, spinal curvature, rib cage depression, and multiple congenital contractures involving limbs, spinal column, and neck.Native of Mexico[95]
Lycopersicon esculentumLeaves-Oral, mixed with foodSolanidanes, spirosolanes alkaloids, glycoalkaloids, and lycopenes-Columbia sheep, cowsNormalBrain defects and cleft palate.Native of Mexico[96]
Manihot esculentaRhizome50 and 80%Oral, mixed with food during GD0–15Cyanide and cyanogenic compounds (linamarin)-Albino ratsNormalGrowth retardation, limb defects, microcephaly, open eyes, low fetal body weight, embryonic death.Native of Mexico[97]
Mimosa tenuifloraSeeds10%Oral, mixed with food during GD6–21Alkaloids-Wistar ratsNormalCleft palate, scoliosis, bifid sternum, aplasia of sternebraes, hypoplastic sternebrae, hypoplasia of ischium, femur, nasal bone, deformed occipital bone, microphthalmia, lordosis, a shorter head, and weight increased.Native of Mexico[98]
Momordica charantiaFruits and seeds; AqEx2 mL/ratIG, GD7, 11 or 13--Sprague Dawley ratsNormalCryptorchidism, splenomegaly; bilateral testicular, hepatic atrophy; renal hypertrophy; splenomegaly; anencephaly and spinabifida.Introduced from Africa[99]
Montanoa tomentosaLeaves; HAEx (70:30)25 mg/kgIG, GD14–21-Ischemia and oxytocic effectWistar ratsNormalFetal mortality, increased fetal body weight, and maternal bleeding.Native of Mexico[100]
Morinda citrifoliaFruit; AqEx300 mg/kgIG, GD7–15--Wistar ratsNormalDelayed ossification and variations in skull, vertebral column, ribs, forelimbs, hindlimbs, and sternum.Introduced from Asia[101]
Moringa oleiferaLeaves; AqEx3000 ppmIn medium, at segmentation phase during 48 h--Zebra fishWhole embryo cultureAbsence or low heartbeat rate, growth retardation, yolk deformity, stunted tail, and embryotoxicity.Introduced from India[102]
Nicotiana glaucaLeaves, stems, flowers, and woody (contained 0.175–0.23% anabasine)5–8 mg/kgIG, twice a day GD32–41Anabasine (alkaloid)Reduction in fetal movement during by fetal pharmacologic neuromuscular blockadeSpanish-goatsNormalBilateral cleft palate, embryonic/fetal death, resorptions, maxillary hypoplasia, midfacial retrusion, contracture in spine, neck, and legs.Introduced from Argentina and Bolivia[103]
Nicotiana humilis (plumbaginifolia)Leaves; MetEx0.5 mg/kgIG, throughout gestational periodNicotinic alkaloids-Sprague Dawley ratsNormalIncreased the body weight, length; decreased tail length; dysplastic tail, curved tail; behavioral disturbance; delayed opening eyes, incisor eruption and hair appearance.Native of Mexico[104]
Nicotiana tabacumLeaves and stalks; juice-IG, GD4–53Nicotinic alkaloids-Duroc pigNormalCongenital limb deformities and contractures; arthrogryposis.Introduced from Peru[105]
Oxytropis sericeaLeaves and stems-Oral, mixed with food during pregnancySwainsonine alkaloids-Sheep and cattleNormalAbortions, lateral rotation of forelimbs, contracted tendons, anterior flexure, looseness of hock joints, flexure of the carpus, decreased length.Introduced from North America[69]
Perovskia abrotanoidesFlowers; EtEx (95%)0.25 g/kgIP, GD8–11Tanshinones (abietane diterpene)Cytotoxicity and apoptosis inductionCD1 miceNormalResorption, stillborn, polydactyly, spina bifida, aglossia, exencephaly, hydrocephaly, tarsal extensor, gastroschisis, skeletal abnormalities, cranium anomaly, variation in vertebrae, ribs, sternum, pelvis and hind limbs.Introduced from Asia[106]
Peumus boldusLeaves; HAEx800 mg/kgIG, GD7–12Boldine (alkaloid)-Wistar ratsNormalAbsence of paw inferior, external ear, and tail; increase of resorptions; weight decrease.Introduced from Chile[107]
Pinus ponderosaPine needles; isolated acids152 mg/kgIG, twice daily GD250–252Isocupressic acid-CowsNormalAbortion.Native of Mexico[108]
Podophyllum peltatumRoots; AExFive timesTopic, 4 h at the end of 23rd, 24th, 25th, 28th, and 29th weeks of pregnancyPodophyllotoxin (β-D-glucoside)Probably by interference with cellular mitosisHumansNormalSimian crease on the left hand and a preauricular skin tag; polyneuritis, limb malformations, septal heart defects, and intrauterine death.Introduced from North America[109,110]
Prunus serotinaFruits and leaves-Oral, ad libitumCyanide-Yorkshire pigNormalNo tail, no anus, very small external sex organs, hind legs plantarflexed below the hock (most were female).Native of Mexico[111]
Rauwolfia vomitoriaLeaves and roots; EtEx250 mg/kgIG, GD7–11--Wistar ratsNormalDistortion of cardiac muscle nicleiand myocaridial fibers.Introduced from Africa[112]
Ricinus communis-linnSeeds; MetEx600 mg/kgIG, GD1–12Ricin and lectin-Wistar ratsNormalPrevention of implantation, abortion, and significant reduction of fetal parameters; crown-rump length, tail length, and weigh.Introduced from Africa[113]
Ruta chalepensis L.Leaves; AqEx10 mg/kgIP, GD9–17--Swiss Rockefeller miceNormalIncreased frequency of fetal resorption, lower fetal weight, hemivertebra, mesocephaly, spina bifida and skeletal malformations.Introduced from Mediterranean [114]
Ruta graveolensLeaves; AqEx20%Oral, mixed with water GD0–4--Swiss albino miceNormalAbnormal compacted and uncompacted morula, extruded blastomere, embryo transport slightly delayed, retarded embryonic development.Introduced from southern Europe[115]
Senna alataLeaves; HEx1000 mg/kgIG, GD10–18Alkaloids-Wistar ratsNormalFetal death, decrease of implantation sites and corpora lutea; increase of resorption index, pre- and post-implantation losses.Introduced from South America[116]
Silybum marianumSeeds (probably); AqEx200 mg/kgIP, GD6–15Silibinin (flavonolignans)Inhibition of cyclooxygenase and apoptosisBALB/c miceNormalReduction of fetal body weight, and crown-rump length; growth retardation; limb malformations, mandibular hypoplasia, vertebral deviations in normal curvatures, kyphotic body, increased fetal resorption.Introduced from Mediterranean[117]
Solanum tuberosumIsolated from root; α-chaconine and α-solanine4.6 and 10.9 mg/L, respectivelyIn medium, during 96 hSteroidal glycosides and alkaloidsCarbohydrate side chain attached to the 3-OH group of solanidine, appears to be an important factor in teratogenicityXenopusWhole embryo cultureGrowth inhibition, loose gut coiling (miscoiling), misshapen eyes, muscular kinking, microencephaly, lacking in facial and brain structures, mortality.Introduced from Bolivia[118]
Treculia africanaOuter coat fruit; HAEX (50%)2.5 mg/kgSC, GD6Polyphenol-Wistar ratsNormalReduction of fetal body weight, hydrocephaly, anophthalmia, omphalocele, shift in position, bipartite vertrabral, rudimentary ribs, fused ribs, extra ribs.Introduced from Africa[119]
Trigonella foenum graecumSeeds; AqEx1000 mg/kgIG, during entire period of pregnancyDiosgenin (steroid) and alkaloids-Swiss albino miceNormalDecrease in litter size and in fetal body weight, aplasia of external ear, bump on the head, median cleft of lower lip, fetotoxicity.Introduced from Asia[120]
Urtica dioicaLeaves; MetEx1000 mg/kgOral, GD6–16--Swiss albino miceNormalFetal resorption.Native of Mexico[101]
Veratrum californicumRoot and top structures; Oex200 gOral, twice on GD14Alkaloids-SheepNormalCyclopia, fetal death.Native of Mexico[121]
Zingiber officinaleRhizome; AqEx50 g/LOral, mixed with water GD6–15Gingerols and shaogoals-Sprague Dawley ratsNormalEmbryonic loss, advanced skeletal development, increased fetal weight.Introduced from Asia[122]
Information on the teratogenic effect of Mexican plants, details of the part used, type of extract, mechanism, animal model, and congenital anomalies found is presented. Alcoholic extract, AEx; aqueous extract, AqEx; chloroform extract, CEx; ethanolic extract, EtEx; hours post-fertilization, hpf; hexane extract, Hex; hydroalcoholic extract, HAEx; intragastric, IG; intravaginal, IVG; methanol/methylene chloride, Met: MCEx; methanolic extract, MetEx; oily extract, OEx; organic extract, Oex.
According to what was found in this review, the animal species employed for carrying out these investigations were very varied; according to their incidence in the publications, the preferred species was rat (Wistar 20, Sprague Dawley 6, albino 1), followed by mouse (Swiss albino 5, BALB/c 3, CD1 2, albino 2, ICR 1, Swiss Rockefeller 1, not specified 1), and in a few species such as sheep 6 (Columbia 3, not specified 3), cows (5 not specified), goats 3 (Spanish 1, not specified 2), pigs (Duroc 1, Yorkshire 1, not specified 1), fish (zebra 3) cattle (not specified 2), chicken (not specified 1), frog (Xenopus 1), horses (not specified 1), human (Homo sapiens 1), and lambs (not specified 1). The latter demonstrates one of our main premises for conducting this review: livestock is seriously affected by teratogenic plants. Similarly, the preferred route of treatment administration was intragastric by gavage (31), followed by orally mixed with food or water (16), intraperitoneally (8), in culture medium (5), subcutaneously (1), and topically (1). All were administered during the critical period of gestation (organogenesis) or during the most susceptible stages of pregnancy in order to obtain suspected alterations.
The majority of species used in the teratogenicity studies in this review are rat and mouse, which is not uncommon, because, for a long time, they have been utilized as the preferred species for scientific research due to being readily available, small in size, easy to handle, easy to maintain, they have a short life cycle, etc. This is not to mention that there is much accessible information on their very similar physiological, anatomical, and genetic characteristics to those of humans [123], a similarity that would be more difficult to obtain in other models, such as fish, birds, or amphibians. In this context, the remarkable anatomical and physiological similarities between animals (particularly mammals) and humans have made possible the development of studies in different areas to investigate the physiological processes, mechanisms of action, efficacy, and the toxicity of drugs in developmental animal models before applying these models to humans [124].
While in preclinical toxicology the use of animals is a highly appreciated resource due to their resemblance to humans, it is evident that not all of the results obtained in animals can be directly translated into a very complex organism. In organisms such as humans, the organs perform distinct highly integrated and regulated physiological functions that involve a complex network of hormones, circulating factors, and cross communication between cells in other compartments, to say the least. Therefore, before thinking about extrapolating to humans the results obtained in animal models, it is necessary to investigate these at all required levels in order to obtain a complete description and an understanding of the involved mechanisms. In this latter aspect, many authors consider that a predominant reason for the poor rate of translation in some studies between animals and humans lies not in the lack of similarity between the species, but in problems of internal validity in preclinical animal studies (poor study design, lack of measures to control bias, etc.) [125].
Since in toxicity tests it is possible to reproduce the toxic effects in different species, for several years investigators have sought an animal species that responds in the same manner as humans to intoxications, to establish a practical model that aids in efficiently extrapolating the toxic effects observed in animals toward humans. However, the conclusion reached was that no animal, not even the higher primates, responds precisely in the same way that humans do against toxic substances [126]. Variability among species is so significant that even within a species such as that of the human, we can find individuals of the same race who respond differently to the same substance/molecule [127]. However, as Litchfield [128] demonstrated, more than one half century ago by comparing 89 effects of 6 toxic substances on rat, dog, and human, the problem is not qualitative, but quantitative. The author concluded that when a toxic effect does not appear in any of the former two species (dog or rat), it will not appear in humans either. However, if the substance affects only one of these, it will also affect humans. Thus, these toxicity tests are not designed to prove that a compound is safe, but instead to characterize the effects that it can produce in animals to produce a series of considerations such as metabolic rate, size, anatomical compartments, pathological state, physiological barriers, among others, which allow for an estimation of the intensity of the expected effects on humans.
Herein we find the importance of the data collected in this review, in which we can observe that the majority of the studies were carried out in species that share physiological similarities with human, rat, and mouse (and only one of these in human). Therefore, according to what has already been stated, it is to be expected that the plants analyzed in this review (or their extracts), when ingested or exposed to developing humans, produce similar alterations (qualitative) to those generated in rat or mouse murine models, varying only in the intensity of said alteration (quantitative).
Although in our review only a sole case of teratogenicity in humans by plants was found, this does not imply that plants do not generate alterations in the development of humans. Simply, at the time of birth, various alterations can go unnoticed if the medical staff does not have adequate preparation, not to mention that the population that uses plants to relieve their ailments and illnesses are mostly low-income persons who do not usually present at medical care centers. In this way, the lack of evidence of teratogenicity in humans (clinical cases) in this bibliographic review due to the consumption of medicinal plants does not comprise evidence of their absence. However, it is evidence of the need to intensify research in this area.
Second, the developmental alterations found in both livestock and laboratory animals were varied to such a degree that their specific description would be unsuccessful. Therefore, we will only mention the most significant alterations produced by the main compounds. The main alterations produced by plants with alkaloids were a decrease in fetal weight and length, altered body-shape morphology, and contracted tendons; encephalocele, phocomelia, and cleft palate, abnormalities in digits, forelimbs, hindlimbs, skull, spinal deformities, a reduction in ossification centers, and a higher rate of resorption, embryotoxicity, and fetal death. For plants with terpenes, we find palatosquisis, acampsia, ear heterotopic, micrognathia, gastroschisis, encephalocele, polydactyly, scoliosis, hemorrhage, spinal cord protrusion, eye protrusion, exencephaly, hydrocephaly and anomalies in the urinary system, variation in vertebrae, ribs, sternum, pelvis, hind limbs and skull post-implantation losses, and resorption. For plants with flavonoids, these are as follows: body deformities; kink tail; bent trunk; limb malformations; mandibular hypoplasia; decrease in fetal weight and crown–rump length; malformed limbs; vertebral deviations, and increased and fetal resorption. For plants with cyanide, these are the following: growth retardation; limb defects; microcephaly; open eyes; low fetal body weight; no tail; no anus; very small external sex organs, and embryonic death. The exact mechanisms by which these alterations occurred have not been fully clarified. However, the consulted authors point out or suspect that the main causing mechanisms in the observed teratogenic effect include oxidative stress [62], ischemia [100], enzymatic inhibition [88,117], alteration in levels of estrogens [91], cytotoxicity [106], apoptosis [117], interference with cellular mitosis [109,110], and restricted fetal movement [76,77,95], among others. Obviously, such alterations can be produced by each one of these or by combinations of these mechanisms (Figure 1).
The last important data obtained from our review are the number of native and introduced teratogenic plants in Mexico. According to our results, of the 63 teratogenic species of Mexican plants found, 19 are native to the country while the 44 remaining plants were introduced during the last 5 centuries from Africa (10), Asia (10), South America (8), India (5), the Mediterranean region (4), North America (4), and Europe (3) (Figure 2). These data, in addition to exhibiting the botanical wealth of Mexico, also reveal to us an important part of the notable cultural influences that Mexico has received from the world. Note that, with respect to these 44 introduced species, many of their genera are present natively (with different species) in Mexico, including Solanum (143), Croton (127), Astragalus (92), Lupinus (80), Senna (62), Indigofera (33), Cinnamomum (23), Artemisia (11), Nicotiana (10), Descurainia (8), Morinda (3), Garcinia (2), and Alstonia (1) [34]. It is logical to suppose that many of these “not studied species”, by sharing the genus with species that have shown teratogenic effects in the laboratory, must share the same or similar families of metabolites with the ability to modify fetal/embryonic development.
In this regard, Astragalus and Lupinus are the more interesting genera due to their high number of species distributed in Mexico and the severe malformations that they generate in livestock. Additionally, although Solanum and Croton are two of the most important genera in Mexico due to their high variety of species, in our review no reports were found indicating that they have affected livestock (the teratogenic effect of these two genera were proven only in mouse and frog). This does not mean that these genera do not affect livestock, but simply that these effects have not yet been documented or studied, rendering novel opportunities.

3.2. Sacred Plants from Mexico

Additionally, it is important to consider that there are some species of Mexican plants that contain considerable amounts of the most common teratogenic compounds in nature, that is, alkaloids, but their teratogenic effect, to our knowledge, has not been investigated. Such is the case of Borago officinalis [134], the genus Senecio [135], and, of course, an important group of Mexican plants termed “sacred” (Table 2). In ancient Mexico (before the Spanish Conquest), plants with toxic properties were usually considered sacred, because their consumption induces mystical outbursts, fear, and alteration of the human mind in order to experience an elevation in consciousness; for this reason, they were bestowed with the personality of deities based on their effects [136]. In this manner, even today, the act of consuming peyote (Lophophora williamsii, America’s most famous sacred hallucinogen) is called by an indigenous group, the Huicholes, as receiving “hikuri,” which means receiving the “heart of the Deer God,” who in turn is known as Tatewari and represents the grandfather god (God of Fire). This deity, the original shaman, collects peyote every year and guides his followers on a mystical pilgrimage to a sacred place where their ancestors rest: Wirikuta [137].
The Mexican sacred plants mentioned in Table 2 possess an important role in rituals and in their medicinal use due to the presence of psychoactive alkaloids, such as psilocybin, mescaline, and ergotamine, among others [138]. However, an important case that we must specify here is that of Salvia devious or hierba de la virgen, which contains a powerful hallucinogenic substance called “salvinorin A,” with a structure similar to that of alkaloids. Nonetheless, it does not contain any nitrogen atom, and, thus, it is not considered as one of these, but rather the first documented diterpene nonalkaloid hallucinogen [139,140,141]. Despite the fact that Salvia divinorum is a sacred plant of great relevance in Mexico, it is addressed outside of Table 2 because, in said table, we find grouped only the Mexican sacred plants whose main hallucinogen components are alkaloids (molecules with great teratogenic capacity), while salvinorin A is a nonalkaloid hallucinogen whose teratogenic potential has not yet been evaluated or related to its particular structure.
The use of plants with ornamental, nutritional, aromatic, medicinal, and religious purposes is widely extended in Mexico [142]. In this respect, sacred plants with biological effects comprise an important element in indigenous medical and religious practices [143]. According to the lack of studies found in this review to evaluate the risks of these sacred plants for embryonic and fetal development, which are commonly used in Mexico, it is necessary to emphasize the danger of their use in the indigenous medical and religious systems. The fact is more alarming if we consider that about 80% of persons worldwide depend on traditional medicine to treat their ailments [144], and that, as stated by the Cámara de Diputados del Congreso de la Unión, the use of sacred plants in Mexico still continues not to be evaluated. Although it is true that Mexico, in subscribing to international treaties, is obliged to prohibit any substance decreed by the World Health Organization (WHO), there is no law in Mexico that punishes the use of these substances. In other words, Mexican legislation sanctions the possession, but not the consumption, of illegal substances, including sacred plants. Therefore, the consumption of hallucinogenic plants such as peyote is legal with only certain restrictions (trafficking) that do not apply to indigenous groups because “ot is an issue of rights regarding the culture and native communities of our country” [145].
Table 2. List of Mexican sacred plants without studies of teratogenicity.
Table 2. List of Mexican sacred plants without studies of teratogenicity.
Scientific NameCommon NameCompoundTypeCite
Ariocarpus retususPeyote cimarronAlkaloidsCactaceae[146]
Argemone mexicanaChicaloteAlkaloidsPlat[147]
ConocybeTeonanácatlAlkaloidsMushroom[148]
Coryphantha compactaBiznaga Partida CompactaAlkaloidsCactaceae[149]
Datura ceratocaula OrtegaTorna locoAlkaloidsPlant[150]
Datura inoxia MillToloacheAlkaloidsPlant[151]
Echinocereus triglochidiatusAlicoche Copa de VinoAlkaloidsCactaceae[152]
Epithelantha micromerisIkuli mulatoAlkaloidsCactaceae[153]
Erytrhina americana MillZumpantle AlkaloidsPlant[154]
Heimia salicifoliaSinicuichiAlkaloidsPlant[155]
Ipomoea violaceaQuiebra platosAlkaloidsPlant[156]
Lophophora williamsiiPeyoteAlkaloidsCactaceae[157]
Lycoperdon mixtecorumHongo de primera claseAlkaloidsMushroom[158]
Mammillaria senilisBiznaga cabeza de viejitosAlkaloidsCactaceae[149]
Pachycereus pecten-aboriginumCardón BarbónAlkaloidsCactaceae[159]
Panaeolus sphinctrinusToshkaAlkaloidsMushroom[160]
Psilocybe caerulescensQuéletAlkaloidsMushroom[160]
Rhynchosia phaseoloidesOjo de cangrejoAlkaloidsPlant[136]
Solandra brevicalyxTecomaxóchitlAlkaloidsPlant[161]
Sophora secundifloraMezcal frijolAlkaloidsPlant[162]
Stropharia cubensisSan IsidroAlkaloidsMushroom[163]
Tagetes lucidaYauhtliAlkaloidsPlant[164]
Turbina corymboseOloliuhquiAlkaloidsPlant[156]
Turnera DiffusaDamianaAlkaloidsPlant[165]
Ungnadia speciosaMonillaAlkaloidsPlant[166]
Information is shown on the alkaloid-rich main Mexican sacred plants that do not, to our knowledge, have scientific studies that evaluate their toxicity on embryo–fetal development.
Finally, we would like to mention that it is advisable to develop a database on non-teratogenic plants, as it is difficult to determine which plants lack a teratogenic effect because, to our knowledge, there are no published studies reporting this. In other words, the corresponding studies may have been carried out, but due to the lack of a teratogenic effect, these resulted as being unattractive for their publication. This catalog of non-teratogenic plants would be very useful in various investigations, both experimental and theoretical.

4. Conclusions

The information compiled in this bibliographic review reveals that there are a considerable number of Mexican plants used in traditional medicine with proven teratogenic effects in laboratory animals and in livestock. The main substances responsible for the teratogenic effects of the plants studied were those of alkaloids, terpenes, and flavonoids. Among the most notable teratogenic effects, alterations to the nervous system, the axial skeleton, and specific systems/structures are highlighted, for which the alkaloids are those mostly responsible.
Many of these plant species share the genus and, most likely, the teratogenic effects with other Mexican plant species on which, to our knowledge, teratogenic studies have not been conducted. Of the 63 species of Mexican plants with a teratogenic effect, 30.15% are native to Mexico, while 69.84% derive from other regions such as Africa, Asia, and South America.
It was determined that there is a group of sacred Mexican plants, attractive due to the presence of alkaloids in their chemical composition and because of the use that they are afforded in traditional medicine and religious practices because of their hallucinogenic effects, which have, to our knowledge, no studies ascribed to them that describe their effects on development.
The biodiversity of plants in Mexico is very extensive: the 63 species with teratogenic effects found in this review barely refer to ≈0.21% of the total species in the country. Therefore, the need to continue exploring the teratogenic potential of Mexican plants is evident, at least beginning with the genera of other species that have already demonstrated their teratogenic effect in the laboratory.

Author Contributions

All authors contributed to the study conception and design. G.C.-C.: Visualization, project administration; M.A.M.-V.: data curation; Y.G.-M.: methodology, data curation, investigation; S.P.-G.: supervision; E.M.-S.: software; N.V.-M.: validation; J.A.M.-G.: writing—reviewing and editing; J.M.C.-L.: conceptualization, writing—original draft preparation, formal analysis. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Not applicable.

Acknowledgments

Melesio Cristóbal wants to express his very great appreciation to Yuliana García-Martínez for her valuable and constructive suggestions during the planning and development of this research work. Likewise, he wishes to reciprocate her love, support and patience throughout the last years: Yuli, do you want to conduct research with me for the rest of our lives? I mean, will you marry me?
“Est osculo gratum speculari semper amatum”
Medieval Aphorism

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Newman, D.J.; Cragg, G.M.; Snader, K.M. The influence of natural products upon drug discovery. Nat. Prod. Rep. 2000, 17, 215–234. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  2. Jamshidi-Kia, F.; Lorigooini, Z.; Amini-Khoei, H. Medicinal plants: Past history and future perspective. J. Herbmed. Pharmacol. 2018, 7, 1–7. [Google Scholar] [CrossRef]
  3. Solecki, R. Shanidar IV a Neanderthal flower burial in Northern Iraq. Science 1975, 190, 880–881. [Google Scholar] [CrossRef]
  4. Qiu, J. Traditional medicine: A culture in the balance. Nature 2007, 448, 126–128. [Google Scholar] [CrossRef]
  5. Hartmann, A. Back to the roots-dermatology in ancient Egyptian medicine. J. Dtsch. Dermatol. Ges. 2016, 14, 389–396. [Google Scholar] [CrossRef] [Green Version]
  6. Balkrishna, A.; Mishra, R.K.; Srivastava, A.; Joshi, B.; Marde, R.; Prajapati, U.B. Ancient Indian rishi’s (Sages) knowledge of botany and medicinal plants since Vedic period was much older than the period of Theophrastus, A case study—Who was the actual father of botany? Int. J. Unani Integr. Med. 2019, 3, 40–44. [Google Scholar]
  7. Petrovska, B.B. Historical review of medicinal plants’ usage. Pharmacogn. Rev. 2012, 6, 1–5. [Google Scholar] [CrossRef] [Green Version]
  8. Ang-Lee, M.K.; Moss, J.; Yuan, C.S. Herbal medicines and perioperative care. JAMA 2001, 286, 208–216. [Google Scholar] [CrossRef]
  9. Palencia, J.S. Presentación. El códice de la cruz Badiano libellus de medicinalibus indorum herbis. Salud Pub. Mex. 1990, 32, 603–617. [Google Scholar]
  10. Casas, A.; Blancas, J.; Lira, R. Mexican Ethnobotany: Interactions of people and plants in Mesoamerica. In Ethnobotany of Mexico; Springer: New York, NY, USA, 2016; Chapter 1; pp. 1–20. [Google Scholar]
  11. Pickersgill, B. Domestication of plants in the Americas: Insights from Mendelian and molecular genetics. Ann Bot. 2007, 100, 925–940. [Google Scholar] [CrossRef] [Green Version]
  12. Ríos, J.L.; Recio, M.C. Medicinal plants and antimicrobial activity. J. Ethnopharmacol. 2005, 100, 80–84. [Google Scholar] [CrossRef]
  13. Madsen, H.L.; Bertelsen, G. Spices as antioxidants. Trends Food Sci. Technol. 1995, 6, 271–277. [Google Scholar] [CrossRef]
  14. Staub, P.O.; Casu, L.; Leonti, M. Back to the roots: A quantitative survey of herbal drugs in Dioscorides’ De Materia Medica (ex Matthioli, 1568). Phytomedicine 2016, 23, 1043–1052. [Google Scholar] [CrossRef]
  15. Singh, N.; Savita, S.; Rithesh, K.; Shivanand, S. Phytotherapy: A novel approach for treating periodontal disease. J. Pharm. Biomed. Sci. 2016, 6, 205–210. [Google Scholar] [CrossRef]
  16. McIntyre, L. Dark Ages: The Case for a Science of Human Behavior; The MIT Press: Cambridge, MA, USA, 2006; p. 15. [Google Scholar]
  17. Guthrie, L.S. Monastic cataloging and classification and the beginnings of “class b” at the library of congress. Cat. Classif Q. 2003, 35, 447–465. [Google Scholar] [CrossRef]
  18. Cragg, G.; Newman, D.J. Natural product drug discovery in the next millennium. Pharm. Biol. 2001, 39, 8–17. [Google Scholar] [CrossRef] [Green Version]
  19. Hamarneh, S. The rise of professional pharmacy in Islam. Med. Hist. 1962, 6, 59–66. [Google Scholar] [CrossRef] [Green Version]
  20. Dunlop, D.M.; Denston, T.C. The history and development of the British Pharmacopoeia. Br. Med. J. 1958, 2, 1250–1252. [Google Scholar] [CrossRef]
  21. Grabley, S.; Thiericke, R. Bioactive agents from natural sources: Trends in discovery and application. Adv. Biochem. Eng. Biotechnol. 1999, 64, 101–154. [Google Scholar] [CrossRef]
  22. Thorburn, A.L. Paul Ehrlich: Pioneer of chemotherapy and cure by arsenic (1854–1915). Br. J. Vener. Dis. 1983, 59, 404–405. [Google Scholar] [CrossRef]
  23. Gu, J.; Zhang, J.; Wang, X.; Wang, G. Convenient new synthesis of umeclidinium bromide. Synth. Commun. 2018, 48, 995–1000. [Google Scholar] [CrossRef]
  24. Tsoucalas, G.; Karamanou, M.; Androutsos, G. Travelling through time with aspirin, a healing companion. Eur. J. Inflamm. 2011, 9, 13–16. [Google Scholar] [CrossRef]
  25. Bulduk, I.; Gezer, B.; Cengiz, M. Optimization of ultrasound-assisted extraction of morphine from capsules of Papaver somniferum by response surface methodology. Int. J. Anal. Chem. 2015, 2015, 796349. [Google Scholar] [CrossRef] [Green Version]
  26. Whayne, T.F., Jr. Clinical use of digitalis: A state of the art review. Am. J. Cardiovasc. Drugs 2018, 18, 427–440. [Google Scholar] [CrossRef]
  27. Colorado, I.R. Obtaining diosgenin from the barbasco. Rev. Inst. Salubr. Enferm. Trop. 1962, 22, 71–73. [Google Scholar]
  28. Blakemore, D.C.; Castro, L.; Churcher, I.; Rees, D.C.; Thomas, A.W.; Wilson, D.M.; Wood, A. Organic synthesis provides opportunities to transform drug discovery. Nat. Chem. 2018, 10, 383–394. [Google Scholar] [CrossRef]
  29. Tandon, S.; Sharma, S.; Rajput, R.; Semwal, B.; Yadav, P.K.; Singh, K. Biotech drugs: The next boom in pharmaceutical market. JPRP 2011, 1, 76–79. [Google Scholar]
  30. Shen, B. A new golden age of natural products drug discovery. Cell 2015, 163, 1297–1300. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  31. Juárez, A.; Carranza, C.; Alonso, A.; González, V.; Bravo, E.; Chamarro, F.; Solano, E. Ethnobotany of medicinal plants used in Xalpatlahuac, Guerrero, México. J. Ethnopharmacol. 2013, 148, 521–527. [Google Scholar] [CrossRef] [PubMed]
  32. Consejo Estatal Para el Desarrollo Integral de los Pueblos Indígenas del Estado de México (CEDIPIEM). (S.F.). La Medicina Tradicional. Available online: http://portal2.edomex.gob.mx/cedipiem/pueblosindigenas/cultura/medicinatradicional/index.html (accessed on 6 May 2015).
  33. Lee, J.W.; Lee, W.B.; Kim, W.; Min, B.I.; Lee, H.; Cho, S.H. Traditional herbal medicine for cancer pain: A systematic review and meta-analysis. Complement. Ther. Med. 2015, 23, 265–274. [Google Scholar] [CrossRef] [PubMed]
  34. Villaseñor, J.L. Checklist of the native vascular plants of Mexico. Rev. Mex. Biodivers. 2016, 87, 559–902. [Google Scholar] [CrossRef] [Green Version]
  35. Villaseñor, J.L. Diversidad y distribución de las magnoliophyta de México. Interciencia 2003, 28, 160–167. [Google Scholar]
  36. Palma-Tenango, M.; Miguel-Chávez, R.S.; Soto-Hernández, R.M. Aromatic and Medicinal Plants in Mexico. Chapter 7: Aromatic and medicinal plants in Mexico. In Aromatic and Medicinal Plants; InTech: London, UK, 2017. [Google Scholar] [CrossRef] [Green Version]
  37. McAleer, I. Renal Development. In Avery’s Diseases of the Newborn, 10th ed.; Elsevier Inc.: Amsterdam, The Netherlands, 2018; pp. 1238–1249. [Google Scholar] [CrossRef]
  38. Vargesson, N.; Fraga, L. Teratogenesis. eLS 2017, a0026056, 1–7. [Google Scholar] [CrossRef]
  39. Cassina, M.; Cagnoli, G.A.; Zuccarello, D.; Di Gianantonio, E.; Clementi, M. Human teratogens and genetic phenocopies. Understanding pathogenesis through human genes mutation. Eur. J. Med. Genet. 2017, 60, 22–31. [Google Scholar] [CrossRef]
  40. Jacobo-Herrera, N.J.; Jacobo-Herrera, F.E.; Zentella-Dehesa, A.; Andrade-Cetto, A.; Heinrich, M.; Pérez-Plasencia, C. Medicinal plants used in Mexican traditional medicine for the treatment of colorectal cancer. J. Ethnopharmacol. 2016, 179, 391–402. [Google Scholar] [CrossRef]
  41. Bautista-Cruz, A.; Arnaud-Viñas, M.R.; Martínez-Gutiérrez, G.A.; Sánchez-Medina, P.S.; Pacheco, R.P. The traditional medicinal and food uses of four plants in Oaxaca, Mexico. J. Med. Plants Res. 2011, 5, 3404–3411. [Google Scholar]
  42. Laveaga, G.S. Mexico’s Historical Models for Providing Rural Healthcare. In Health for All: The Journey of Universal Health Coverage; Medcalf, A., Bhattacharya, S., Momen, H., Saavedra, M., Jones, M., Eds.; Orient Blackswan: Hyderabad, Indian, 2015; Chapter 4. Available online: https://www.ncbi.nlm.nih.gov/books/NBK316259/ (accessed on 12 November 2021).
  43. van Gameren, E. Health insurance and use of alternative medicine in Mexico. Health Policy 2010, 98, 50–57. [Google Scholar] [CrossRef] [Green Version]
  44. Govea-Salas, M.; Morlett-Chávez, J.; Rodriguez-Herrera, R.; Ascacio-Valdés, J. Some Mexican Plants Used in Traditional Medicine. In Aromatic and Medicinal Plants—Back to Nature; InTech: London, UK, 2017; Chapter 10. [Google Scholar] [CrossRef] [Green Version]
  45. Valdivia-Correa, B.; Gómez-Gutiérrez, C.; Uribe, M.; Méndez-Sánchez, N. Herbal Medicine in Mexico: A Cause of Hepatotoxicity. A Critical Review. Int. J. Mol. Sci. 2016, 17, 235. [Google Scholar] [CrossRef] [Green Version]
  46. Alonso-Castro, A.J.; Ruiz-Padilla, A.J.; Ruiz-Noa, Y.; Alba-Betancourt, C.; Domínguez, F.; Ibarra-Reynoso, L.; Maldonado-Miranda, J.J.; Carranza-Álvarez, C.; Blanco-Sandate, C.; Ramírez-Morales, M.A.; et al. Self-medication practice in pregnant women from central Mexico. Saudi Pharm. J. 2018, 26, 886–890. [Google Scholar] [CrossRef]
  47. Cortinovis, C.; Caloni, F. Alkaloid-Containing Plants Poisonous to Cattle and Horses in Europe. Toxins 2015, 7, 5301–5307. [Google Scholar] [CrossRef] [Green Version]
  48. Almli, L.M.; Ely, D.M.; Ailes, E.C.; Abouk, R.; Grosse, S.D.; Isenburg, J.L.; Waldron, D.B.; Reefhuis, J. Infant Mortality Attributable to Birth Defects—United States, 2003–2017. Morb. Mortal. Wkly. Rep. 2020, 69, 25–29. [Google Scholar] [CrossRef] [Green Version]
  49. Soares, M.C.; Pupin, R.C.; Guizelini, C.C.; Gaspar, A.O.; Gomes, D.C.; Brumatti, R.C.; Lemos, R.A.A. Economic losses due to Vernonia rubricaulis poisoning in cattle. Pesq. Vet. Bras. 2018, 38, 2217–2223. [Google Scholar] [CrossRef]
  50. Invasive Species Compendium (ISC). CAB International: Wallingford, UK. Available online: www.cabi.org/isc (accessed on 30 August 2021).
  51. Herbario Virtual Conabio (HVC). Available online: http://www.conabio.gob.mx/otros/cgi-bin/herbario.cgi (accessed on 5 August 2021).
  52. Naturalista. CONABIO. Available online: http://www.naturalista.mx (accessed on 15 August 2021).
  53. Flora del Noroeste de México. 2021. Available online: http://www.herbanwmex.net/portal/index.php (accessed on 4 September 2021).
  54. Jing, H.; Liu, J.; Liu, H.; Xin, H. Histochemical investigation and kinds of alkaloids in leaves of different developmental stages in Thymus quinquecostatus. Sci. World J. 2014, 2014, 839548. [Google Scholar] [CrossRef] [Green Version]
  55. Jaszczak, E.; Polkowska, Ż.; Narkowicz, S.; Namieśnik, J. Cyanides in the environment-analysis-problems and challenges. Environ. Sci. Pollut. Res. Int. 2017, 24, 15929–15948. [Google Scholar] [CrossRef] [Green Version]
  56. Butnariu, M.; Sarac, I. Essential oils from plants. J. Biotechnol. Biomed. Sci. 2018, 1, 35–43. [Google Scholar] [CrossRef] [Green Version]
  57. Dey, P.; Kundu, A.; Kumar, A.; Gupta, M.; Lee, B.M.; Bhakta, T.; Dash, S.; Kim, H.S. Analysis of alkaloids (indole alkaloids, isoquinoline alkaloids, tropane alkaloids). In Recent Advances in Natural Products Analysis; Elsevier: Amsterdam, The Netherlands, 2020; pp. 505–567. [Google Scholar] [CrossRef]
  58. Funayama, A.S.; Cordell, G.A. Alkaloids: A Treasury of Poisons and Medicines; Elsevier: Amsterdam, The Netherlands, 2015; pp. 1–10. [Google Scholar]
  59. Green, B.T.; Lee, S.T.; Welch, K.D.; Panter, K.E. Plant alkaloids that cause developmental defects through the disruption of cholinergic neurotransmission. Birth Defects Res. C Embryo Today 2013, 99, 235–246. [Google Scholar] [CrossRef]
  60. Lemonica, I.P.; Alvarenga, C.M. Abortive and teratogenic effect of Acanthospermum hispidum DC. and Cajanus cajan (L.) Millps. in pregnant rats. J. Ethnopharmacol. 1994, 43, 39–44. [Google Scholar] [CrossRef]
  61. Nana, P.; Asongalem, E.A.; Foyet, H.S.; Folefoc, G.N.; Dimo, T.; Kamtchouing, P. Maternal and developmental toxicity evaluation of Acanthus montanus leaves extract administered orally to Wistar pregnant rats during organogenesis. J. Ethnopharmacol. 2008, 116, 228–233. [Google Scholar] [CrossRef]
  62. Diallo, A.; Batomayena, B.; Povic, L.; Eklu-Gadegbeku, K.; Aklikokou, K.; Creppy, E.; Gbeassor, M. Fetal toxicity of hydroalcoholic extract of Ageratum conyzoides L. leaves (asteraceae) in rats. Int. J. Pharm. Pharm. Sci. 2015, 7, 264–266. [Google Scholar]
  63. Eluwa, M.A.; Otung, G.; Udo-Affah, G.; Ekanem, T.B.; Mesembe, O.; Au, A. Teratogenic effect of maternal administration of aloe vera extract on foetal morphology and the histology of the foetal kidney. Glob. J. Med. Sci. 2006, 5, 41–44. [Google Scholar] [CrossRef]
  64. Herrera, A.A.; Dee, A.M.O.; Ipulan, L.A. Detection of congenital anomalies in Mus musculus induced by crude leaf extracts of Goniothalamus amuyon (Blanco) Merr. and Alstonia macrophylla Wall. Ex G. Don. J. Med. Plant Res. 2010, 4, 327–334. [Google Scholar] [CrossRef]
  65. Jagetia, G.C.; Baliga, M.S. Induction of developmental toxicity in mice treated with Alstonia scholaris (Sapthaparna) In utero. Birth Defects Res. B Dev. Reprod. Toxicol. 2003, 68, 472–478. [Google Scholar] [CrossRef] [PubMed]
  66. Boareto, A.C.; Muller, J.C.; Bufalo, A.C.; Botelho, G.G.K.; De Araujo, S.L.; Foglio, M.A.; Dalsenter, P.R. Toxicity of artemisinin [Artemisia annua L.] in two different periods of pregnancy in Wistar rats. Reprod. Toxicol. 2008, 25, 239–246. [Google Scholar] [CrossRef] [PubMed]
  67. James, L.F. Effect of locoweed (Astragalus lentiginosus) feeding of fetal lamb development. Can. J. Comp. Med. 1976, 40, 380–384. [Google Scholar] [PubMed]
  68. Hanson, G. The Toxicity of Plants in Equines, a Modern Three-Point Approach to Disseminating Information. Master’s Thesis, University of Idaho, Moscow, ID, USA, 2008; pp. 83–89. [Google Scholar]
  69. James, L.F.; Shupe, J.L.; Binns, W.; Keeler, R.F. Abortive and teratogenic effects of locoweed on sheep and cattle. Am. J. Vet. Res. 1967, 28, 379–1388. [Google Scholar]
  70. Dallaqua, B.; Saito, F.H.; Rodrigues, T.; Calderon, I.M.; Rudge, M.V.; Volpato, G.T.; Damasceno, D.C. Azadirachta indica treatment on the congenital malformations of fetuses from rats. J. Ethnopharmacol. 2013, 150, 1109–1113. [Google Scholar] [CrossRef]
  71. Lemonica, I.P.; Macedo, A.M.R.B. Borro Macedo. Abortive and/or embryofetotoxic effect of Cinnamomum zeylanicum leaf extracts in pregnant rats. Fitoter 1994, 65, 431–434. [Google Scholar]
  72. Abel, E.L.; Rockwood, G.A.; Riley, E.P. The Effects of Early Marijuana Exposure. In Handbook of Behavioral Teratology; Riley, E.P., Vorhees, C.V., Eds.; Springer: Boston, MA, USA, 1986. [Google Scholar] [CrossRef]
  73. Persaud, T.V.; Ellington, A.C. The effects of Cannabis sativa L. (Ganja) on developing rat embryos--preliminary observations. West Indian Med. J. 1968, 17, 232–234. [Google Scholar]
  74. Nobakht, M.; Fattahi, M.; Hoormand, M.; Milanian, I.; Rahbar, N.; Mahmoudian, M. A study on the teratogenic and cytotoxic effects of safflower extract. J. Ethnopharmacol. 2000, 73, 453–459. [Google Scholar] [CrossRef]
  75. Traesel, G.K.; De Lima, F.F.; Dos Santos, A.C.; Souza, R.I.C.; Cantadori, D.T.; Kretschmer, C.R.; Navarini, V.J.; Oesterreich, S.A. Evaluation of embryotoxic and teratogenic effects of the oil extracted from Caryocar brasiliense Cambess pulp in rats. Food Chem. Toxicol. 2017, 110, 74–82. [Google Scholar] [CrossRef]
  76. Green, B.T.; Lee, S.T.; Panter, K.E.; Brown, D.R. Piperidine alkaloids: Human and food animal teratogens. Food Chem. Toxicol. 2012, 50, 2049–2055. [Google Scholar] [CrossRef] [Green Version]
  77. Keeler, R.F. Coniine, a teratogenic principle from Conium maculatum producing congenital malformations in calves. Clin. Toxicol. 1974, 7, 195–206. [Google Scholar] [CrossRef]
  78. Keller, K. Cinnamomum Species. In Adverse Reactions of Herbal Drugs; De Smet, P.A.G.M., Keller, K., Hänsel, R., Chandler, R.F., Eds.; Springer: Berlin/Heidelberg, Germany, 1992; pp. 105–114. [Google Scholar]
  79. Wabai, Y.W.; Maina, M.K.J.; Mwaniki, N.E. Teratogenic potential of Urtica massaica (Mildbr.) and Croton megalocarpus (Hutch) in mice. J. Phytopharmacol. 2018, 7, 460–463. [Google Scholar] [CrossRef]
  80. Alafiatayo, A.A.; Lai, K.S.; Syahida, A.; Mahmood, M.; Shaharuddin, N.A. Phytochemical Evaluation, Embryotoxicity, and Teratogenic Effects of Curcuma longa Extract on Zebrafish (Danio rerio). Evid. Based Complement. Altern. Med. 2019, 2019, 3807207. [Google Scholar] [CrossRef] [Green Version]
  81. Ramesh, C.G. Reproductive and Developmental Toxicology; Chapter 51: Toxic Plants; Academic Press: San Diego, CA, USA, 2011; p. 690. [Google Scholar]
  82. Tolentino, J.J.V.; Undan, J.R. Embryo-Toxicity and Teratogenicity of Derris elliptica Leaf Extract on Zebra Fish (Danio rerio) Embryos. Int. J. Pure App. Biosci. 2016, 4, 16–20. [Google Scholar] [CrossRef]
  83. Kuete, V. Toxicological Survey of African Medicinal Plants; Elsevier: New York, NY, USA, 2014; p. 266. [Google Scholar]
  84. Akpantah, A.O.; Oremosu, A.A.; Noronha, C.C.; Ekanem, T.B.; Okanlawon, A.O. Effects of garcinia kola seed extract on ovulation, oestrous cycle and foetal development in cyclic female sprague-dawley rats. Niger. J. Physiol. Sci. 2005, 20, 58–62. [Google Scholar]
  85. Khalid, M.; Tahir, M.; Shoro, A. Ginseng induced fetal skeletal malformations. Biomedica 2008, 24, 96–98. [Google Scholar]
  86. Pearn, J.H. Studies on a site-specific cleft palate teratogen. The toxic extract from Indigofera spicata Forssk. Br. J. Exp. Pathol. 1967, 48, 620–626. [Google Scholar]
  87. Zoriki-Hosomi, R.; Spinosa, H.; Lima-Górniak, S.; Ferreira-Habr, S.; Witaker-Penteado, S.; Fantinato-Varoli, F.M.; Bernardi, M.M. Embryotoxic effects of prenatal treatment with Ipomoea carnea aqueous fraction in rats. Braz. J. Vet. Res. Anim. Sci. 2008, 45, 67–75. [Google Scholar] [CrossRef] [Green Version]
  88. Cristóbal-Luna, J.M.; Paniagua-Castro, N.; Escalona-Cardoso, G.N.; Pérez-Gutiérrez, M.S.; Álvarez-González, I.; Madrigal-Bujaidar, E.; Chamorro-Cevallos, G. Evaluation of teratogenicity and genotoxicity induced by kramecyne (KACY). Saudi Pharm. J. 2018, 26, 829–838. [Google Scholar] [CrossRef]
  89. Mello, F.B.; Jacobus, D.; Carvalho, K.; Mello, J.R.B. Effects of Lantana camara (Verbenaceae) on general reproductive performance and teratology in rats. Toxicon 2005, 45, 459–466. [Google Scholar] [CrossRef]
  90. Sarhadi, Z.; Torabzadeh, P.; Ramezani, M. Assessment of the Teratogenic Effects of Aqueous Extract of Lavandula angustifolia on BALB/c Female Mouse’s Embryos in the 3rd, 4th, 5th and 6th Days of Gestation. J. Anim. Biol. 2019, 11, 35–45. [Google Scholar]
  91. Esteki, R.; Miraj, S. The Abortificient Effects of Hydroalcoholic Extract of Lawsonia Inermis on BALB/c Mice. Electron. Physician 2016, 8, 2568–2575. [Google Scholar] [CrossRef] [Green Version]
  92. Sastry, M.S.; Singh, R. Toxic effects of subabul (Leucaena leucocephala) on the thyroid and reproduction of female goats. Indian J. Anim. Sci. 2008, 78, 251–253. [Google Scholar]
  93. Barilli, S.L.S.; Dos Santos, S.T.; Montanari, T. Efeito do Decocto dos Frutos de Buchinha-do-Norte (Luffa operculata Cogn.) Sobre a Reprodução Feminina e o Desenvolvimento Embrionário e fetal, 10 a 12 de maio. Semana da Enfermagem: A enfermagem e o Desafio da Integralidade em Saúde. 2006. Available online: www.tinyurl.com/ybd3h4ye (accessed on 14 August 2021).
  94. Panter, K.E.; James, L.F.; Keeler, R.F.; Bunch, T.D. Radio-ultrasound observations of poisonous plant–induced fetotoxicity in livestock. In Poisonous Plants: Proceedings of the Third International Symposium; James, L.F., Keeler, R.F., Bailey, E.M., Panter, K.E., Bunch, T.D., Eds.; Iowa State University Press: Ames, IA, USA, 1992; pp. 481–488. [Google Scholar]
  95. Keeler, R.F.; Panter, K.E. Piperidine alkaloid composition and relation to crooked calf disease–inducing potential of Lupinus formosus. Teratology 1989, 40, 423–432. [Google Scholar] [CrossRef]
  96. James, L.F.; Keeler, R.F.; Binns, W. Sequence in the abortive and teratogenic effects of locoweed fed to sheep. Am. J. Vet. Res. 1969, 30, 377–380. [Google Scholar]
  97. Singh, J.D. The teratogenic effects of dietary cassava on the pregnant albino rat: A preliminary report. Teratology 1981, 24, 289–291. [Google Scholar] [CrossRef]
  98. Medeiros, R.M.T.; De Figueiredo, A.P.M.; Benício, T.M.A.; Dantas, F.P.M.; Riet-Correa, F. Teratogenicity of Mimosa tenuiflora seeds to pregnant rats. Toxicon 2008, 51, 316–319. [Google Scholar] [CrossRef]
  99. Uche-Nwachi, E.O.; McEwen, C. Teratogenic effect of the water extract of bitter gourd (Momordica charantia) on the Sprague Dawley rats. Afr. J. Tradit. Complement. Altern. Med. 2009, 7, 24–33. [Google Scholar] [CrossRef] [Green Version]
  100. Moy, N.A. Efectos Farmacológicos y Toxicológicos de Extractos Hidroalcohólicos de Zoapatle (Montanoa tomentosa) en Rata Biodisponibilidad Después de Administración Intravaginal; Universidad de Colima: Colima, México, 1998; pp. 3–4. [Google Scholar]
  101. Marques, N.F.; Marques, A.P.; Iwano, A.L.; Golin, M.; De-Carvalho, R.R.; Paumgartten, F.J.; Dalsenter, P.R. Delayed ossification in Wistar rats induced by Morinda citrifolia L. exposure during pregnancy. J. Ethnopharmacol. 2010, 128, 85–91. [Google Scholar] [CrossRef]
  102. David, C.R.S.; Angeles, A.; Angoluan, R.C.; Santos, J.P.E.; David, E.S.; Dulay, R.M.R. Moringa oleifera (Malunggay) Water Extracts Exhibit Embryo-toxic and Teratogenic Activity in Zebrafish (Danio rerio) Embryo Model. Der Pharm. Lett. 2016, 8, 163–168. [Google Scholar] [CrossRef]
  103. Panter, K.E.; Weinzweig, J.; Gardner, D.R.; Stegelmeier, B.L.; James, L.F. Comparison of cleft palate induction by Nicotiana glauca in goats and sheep. Teratology 2000, 61, 203–210. [Google Scholar] [CrossRef]
  104. Khalki, H.; Khalki, L.; Aboufatima, R.; Ouachrif, A.; Mountassir, M.; Benharref, A.; Chait, A. Prenatal exposure to tobacco extract containing nicotinic alkaloids produces morphological and behavioral changes in newborn rats. Pharmacol. Biochem. Behav. 2012, 101, 342–347. [Google Scholar] [CrossRef] [PubMed]
  105. Crowe, M.W.; Swerczek, T.W. Congenital arthrogryposis in offspring of sows fed tobacco (Nicotiana tabacum). Am. J. Vet. Res. 1974, 35, 1071–1073. [Google Scholar]
  106. Moallem, S.A.; Niapour, M. Study of embryotoxicity of Perovskia abrotanoides, an adulterant in folk-medicine, during organogenesis in mice. J. Ethnopharmacol. 2008, 117, 108–114. [Google Scholar] [CrossRef]
  107. Almeida, E.R.; Melo, A.M.; Xavier, H. Toxicological evaluation of the hydro-alcohol extract of the dry leaves of Peumus boldus and boldine in rats. Phytother. Res. PTR 2000, 14, 99–102. [Google Scholar] [CrossRef]
  108. Gardner, D.R.; Molyneux, R.J.; James, L.F.; Panter, K.E.; Stegelmeier, B.L. Ponderosa Pine Needle-Induced abortion in beef cattle: Identification of isocupressic acid as the principal active compound. J. Agric. Food Chem. 1994, 42, 756–761. [Google Scholar] [CrossRef]
  109. Karol, M.D.; Conner, C.S.; Watanabe, A.S.; Murphrey, K.J. Podophyllum: Suspected teratogenicity from topical application. Clin. Toxicol. 1980, 16, 283–286. [Google Scholar] [CrossRef]
  110. Chamberlain, M.J.; Reynolds, A.L.; Yeoman, W.B. Medical memoranda. Toxic effect of podophyllum application in pregnancy. Br. Med. J. 1972, 3, 391–392. [Google Scholar] [CrossRef] [Green Version]
  111. Selby, L.A.; Menges, R.W.; Houser, E.C.; Flatt, R.E.; Case, A.A. Outbreak of swine malformations associated with the wild black cherry, Prunus serotina. Arch. Environ. Health 1971, 22, 496–501. [Google Scholar] [CrossRef]
  112. Eluwa, M.A.; Udoaffah, M.T.; Vulley, M.B.; Ekanem, T.B.; Akpantah, A.O.; Asuquo, O.A.; Ekong, M.B. Comparative study of teratogenic potentials of crude ethanolic root bark and leaf extract of Rauwolfia vomitoria (apocynaceae) on the fetal heart. N. Am. J. Med. Sci. 2010, 2, 592–595. [Google Scholar] [CrossRef]
  113. Ucheya, R.E.; Biose, I.J. Teratogenic effects of methanolic extract of Ricinus communis seed oil on the morphology of foetal wistar rats. Biosci. Biotechnol. Res. Asia 2010, 7, 719–723. [Google Scholar]
  114. Gonzales, J.; Benavides, V.; Rojas, R.; Pino, J. Embryotoxic and teratogenic effect of Ruta chalepensis L. «rue», in mouse (Mus musculus). Rev. Peru. Biol. 2007, 13, 223–226. [Google Scholar]
  115. Gutiérrez-Pajares, J.L.; Zúñiga, L.; Pino, J. Ruta graveolens aqueous extract retards mouse preimplantation embryo development. Reprod. Toxicol. 2003, 17, 667–672. [Google Scholar] [CrossRef]
  116. Yakubu, M.T.; Musa, I.F. Effects of Post-coital Administration of Alkaloids from Senna alata (Linn. Roxb) Leaves on some Fetal and Maternal Outcomes of Pregnant Rats. J. Reprod. Infertil. 2012, 13, 211–217. [Google Scholar]
  117. Gholami, M.; Moallem, S.A.; Afshar, M.; Amoueian, S.; Etemad, L.; Karimi, G. Teratogenic effects of silymarin on mouse fetuses. Avicenna J. Phytomed. 2016, 6, 542–549. [Google Scholar]
  118. Friedman, M.; Rayburn, J.R.; Bantle, J.A. Developmental toxicology of potato alkaloids in the frog embryo teratogenesis assay--Xenopus (FETAX). Food Chem. Toxicol. 1991, 29, 537–547. [Google Scholar] [CrossRef]
  119. Lawal, R.O. Effects of dietary protein on teratogenicity of polyphenols obtained from the outer coat of the fruit of Treculia africana. Food Chem. 1997, 60, 495–499. [Google Scholar] [CrossRef]
  120. Khalki, L.; M’hamed, S.B.; Bennis, M.; Chait, A.; Sokar, Z. Evaluation of the developmental toxicity of the aqueous extract from Trigonella foenum-graecum (L.) in mice. J. Ethnopharmacol. 2010, 131, 321–325. [Google Scholar] [CrossRef]
  121. Keeler, R.F.; Binns, W. Teratogenic compounds of Veratrum californicum (Durand). II. Production of ovine fetal cyclobia by fractions and alkaloid preparations. Can. J. Biochem. 1966, 44, 829–838. [Google Scholar] [CrossRef]
  122. Wilkinson, J.M. Effect of ginger tea on the fetal development of Sprague-Dawley rats. Reprod. Toxicol. 2000, 14, 507–512. [Google Scholar] [CrossRef]
  123. Bryda, E.C. The Mighty Mouse: The impact of rodents on advances in biomedical research. Mo. Med. 2013, 110, 207–211. [Google Scholar]
  124. Barré-Sinoussi, F.; Montagutelli, X. Animal models are essential to biological research: Issues and perspectives. Future Sci. OA 2015, 1, FSO63. [Google Scholar] [CrossRef] [Green Version]
  125. Pound, P.; Ritskes-Hoitinga, M. Is it possible to overcome issues of external validity in preclinical animal research? Why most animal models are bound to fail. Pound and Ritskes? Hoitinga J. Transl. Med. 2018, 16, 304. [Google Scholar] [CrossRef] [Green Version]
  126. Van Norman, G.A. Limitations of Animal Studies for Predicting Toxicity in Clinical Trials: Is it Time to Rethink Our Current Approach? JACC Basic Transl. Sci. 2019, 4, 845–854. [Google Scholar] [CrossRef]
  127. Templeton, A.R. Biological races in humans. Stud. Hist. Philos. Biol. Biomed. Sci. 2013, 44, 262–271. [Google Scholar] [CrossRef] [Green Version]
  128. Litchfield, J.T. Symposium on clinical drug evaluation and human pharmacology. XVI. Evaluation of the safety of new drugs by means of tests in animals. Clin. Pharmacol. Ther. 1962, 3, 665–672. [Google Scholar] [CrossRef]
  129. Library of Congress. Image 286 of General History of the Things of New Spain by Fray Bernardino de Sahagún: The Florentine Codex. Book XI: Natural Things. Available online: https://www.loc.gov/resource/gdcwdl.wdl_10622/?sp=286 (accessed on 13 June 2022).
  130. Red de Herbarios del Noroeste de México. Astragalus mollissimus Torr. Available online: https://herbanwmex.net/portal/taxa/index.php?tid=4122 (accessed on 13 June 2022).
  131. Red de Herbarios del Noroeste de México. Artemisia annua L. Available online: https://herbanwmex.net/portal/taxa/index.php?taxon=Artemisia+annua+&formsubmit=Search+Terms (accessed on 13 June 2022).
  132. Red de Herbarios del Noroeste de México. Silybum marianum (L.) Gaertn. Available online: https://herbanwmex.net/portal/taxa/index.php?taxon=Silybum+marianum&formsubmit=Search+Terms (accessed on 13 June 2022).
  133. TRAMILE Programa de Investigación Aplicada a la Medicina Popular del Caribe. Available online: https://www.tramil.net/es/plant/manihot-esculenta#:~:text=Descripci%C3%B3n%20bot%C3%A1nica,con%20c%C3%A1liz%20campanulado%2C%205%20lobado (accessed on 13 June 2022).
  134. Vacillotto, G.; Favretto, D.; Seraglia, R.; Pagiotti, R.; Traldi, P.; Mattoli, L. A rapid and highly specific method to evaluate the presence of pyrrolizidine alkaloids in Borago officinalis seed oil. J. Mass Spectrom. 2013, 48, 1078–1082. [Google Scholar] [CrossRef]
  135. Langel, D.; Ober, D.; Pelser, P.B. The evolution of pyrrolizidine alkaloid biosynthesis and diversity in the Senecioneae. Phytochem. Rev. 2001, 10, 3–74. [Google Scholar] [CrossRef]
  136. Barba, B. Las plantas sagradas mexicanas. Ciencia 2015, 66, 48–59. [Google Scholar]
  137. Schultes, R.E.; Hofmann, A. Plants of the Gods: Their Sacred, Healing, and Hallucinogenic Powers, 2nd ed.; Healing Arts Press: Rochester, VT, USA, 2001; p. 148. [Google Scholar]
  138. Díaz, J.L. Ethnopharmacology of sacred psychoactive plants used by the Indians of Mexico. Annu. Rev. Pharmacol. Toxicol. 1977, 17, 647–675. [Google Scholar] [CrossRef] [PubMed]
  139. Rossi, A.; Pace, S.; Tedesco, F.; Pagano, E.; Guerra, G.; Troisi, F.; Werner, M.; Roviezzo, F.; Zjawiony, J.K.; Werz, O.; et al. The hallucinogenic diterpene salvinorin A inhibits leukotriene synthesis in experimental models of inflammation. Pharmacol. Res. 2016, 106, 64–71. [Google Scholar] [CrossRef] [PubMed]
  140. Roth, B.L.; Baner, K.; Westkaemper, R.; Siebert, D.; Rice, K.C.; Steinberg, S.; Ernsberger, P.; Rothman, R.B.; Salvinorin, A. A potent naturally occurring nonnitrogenous kappa opioid selective agonist. Proc. Natl. Acad. Sci. USA 2002, 99, 11934–11939. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  141. Valdés, L.J., 3rd. Salvia divinorum and the unique diterpene hallucinogen, Salvinorin (divinorin) A. J. Psychoact. Drugs 1994, 26, 277–283. [Google Scholar] [CrossRef]
  142. Reimers, E.A.L.; Fernández, E.C.; Reimers, D.J.L.; Chaloupkova, P.; Del Valle, J.M.Z.; Milella, L.; Russo, D. An Ethnobotanical Survey of Medicinal Plants Used in Papantla, Veracruz, Mexico. Plants 2019, 8, 246. [Google Scholar] [CrossRef] [Green Version]
  143. Heinrich, M.; Ankli, A.; Frei, B.; Weimann, C.; Sticher, O. Medicinal plants in Mexico: Healers’ consensus and cultural importance. Soc. Sci. Med. 1998, 47, 1859–1871. [Google Scholar] [CrossRef]
  144. Yabesh, J.E.M.; Prabhu, S.; Vijayakumar, S. An ethnobotanical study of medicinal plants used by traditional healers in silent valley of Kerala, India. J. Ethnopharmacol. 2014, 154, 774–789. [Google Scholar] [CrossRef]
  145. Cámara de Diputados del Congreso de la Unión, LXIV Legislatura. Necesario Legislar Sobre Plantas Sagradas; Boletín 3979; son Patrimonio Nacional: Nava Palacios. México, 2017. Available online: http://www5.diputados.gob.mx/index.php/esl/Comunicacion/Boletines/2017/Agosto/29/3979-Necesario-legislar-sobre-plantas-sagradas-son-patrimonio-nacional-Nava-Palacios (accessed on 24 August 2020).
  146. Rodríguez, R.G.; Morales, M.E.; Verde, M.J.; Oranday, A.; Rivas, C.; Núñez, M.A.; González, G.M.; Treviño, J.F. Actividad antibacteriana y antifúngica de las especies Ariocarpus kotschoubeyanus (Lemaire) y Ariocarpus retusus (Scheidweiler) (Cactaceae). Rev. Mex. Cienc. Farm. 2010, 41, 55–59. [Google Scholar]
  147. Singh, S.; Verma, M.; Malhotra, M.; Prakash, S.; Singh, T.D. Cytotoxicity of alkaloids isolated from Argemone mexicana on SW480 human colon cancer cell line. Pharm. Biol. 2016, 54, 740–745. [Google Scholar] [CrossRef]
  148. Reingardiene, D.; Vilcinskaite, J.; Lazauskas, R. Haliucinogeniniai grybai [Hallucinogenic mushrooms]. Medicina 2005, 41, 1067–1070. [Google Scholar]
  149. Mandujano, M.C.; Gulovob, J.; Reyes, J. Lo que usted siempre quiso saber sobre las cactaceas y nunca se atrevio a preguntar. CONABIO. Biodiversitas 2002, 40, 4–7. [Google Scholar]
  150. Berkov, S. Alkaloids of Datura ceratocaula. Z. Naturforsch. C. J. Biosci. 2003, 58, 455–458. [Google Scholar] [CrossRef]
  151. Malinowska, I.; Studziński, M.; Niezabitowska, K.; Gadzikowska, M. Comparison of TLC and Different Micro TLC Techniques in Analysis of Tropane Alkaloids and Their Derivatives Mixture from Datura inoxia Mill. Extract. Chromatographia 2013, 76, 1327–1332. [Google Scholar] [CrossRef] [Green Version]
  152. Ferrigni, N.R.; Nichols, D.E.; McLaughlin, J.L.; Bye, R.A. Cactus alkaloids. XLVII. N alpha-dimethylhistamine, a hypotensive component of Echinocereus triglochidiatus. J. Ethnopharmacol. 1982, 5, 359–364. [Google Scholar] [CrossRef]
  153. Štarha, R. Alkaloids of Epithelantha micromeris. Fitoterapia 1995, 66, 375. [Google Scholar]
  154. Garín-Aguilar, M.E.; Luna, J.E.; Soto-Hernández, M.; Valencia del Toro, G.; Vázquez, M.M. Effect of crude extracts of Erythrina americana Mill. on aggressive behavior in rats. J. Ethnopharmacol. 2000, 69, 189–196. [Google Scholar] [CrossRef]
  155. Rumalla, C.S.; Jadhav, A.N.; Smillie, T.; Fronczek, F.R.; Khan, I.A. Alkaloids from Heimia salicifolia. Phytochemistry 2008, 69, 1756–1762. [Google Scholar] [CrossRef]
  156. Steiner, U.; Leistner, E. Ergot Alkaloids and their Hallucinogenic Potential in Morning Glories. Planta Med. 2018, 84, 751–758. [Google Scholar] [CrossRef] [Green Version]
  157. Cassels, B.K.; Sáez-Briones, P. Dark Classics in Chemical Neuroscience: Mescaline. ACS Chem. Neurosci. 2018, 9, 2448–2458. [Google Scholar] [CrossRef]
  158. Schultes, R.; Farnsworth, N. Ethnomedical, botanical and phytochemical aspects of natural hallucinogens. In Botanical Museum Leaflets; Harvard University: Cambridge, MA, USA, 1980; Volume 28, pp. 123–214. [Google Scholar]
  159. Strömbom, J.; Bruhn, J.G. Alkaloids of Pachycereus pecten-aboriginum, a Mexican cactus of ethnopharmacologic interest. Acta Pharm. Suec. 1978, 15, 127–132. [Google Scholar]
  160. Mahmood, Z.A. Bioactive Alkaloids from Fungi: Psilocybin. In Natural Products; Ramawat, K., Mérillon, J.M., Eds.; Springer: Berlin/Heidelberg, Germany, 2013. [Google Scholar] [CrossRef]
  161. Qu, J.; Hu, Y.C.; Li, J.B.; Wang, Y.H.; Zhang, J.L.; Abliz, Z.; Yu, S.S.; Liu, Y.B. Structural characterization of constituents with molecular diversity in fractions from Lysidice brevicalyx by liquid chromatography/diode-array detection/electrospray ionization tandem mass spectrometry and liquid chromatography/nuclear magnetic resonance. Rapid Commun. Mass Spectrom. 2008, 22, 755–765. [Google Scholar] [CrossRef]
  162. Izaddoost, M.; Harris, B.G.; Gracy, R.W. Structure and toxicity of alkaloids and amino acids of Sophora secundiflora. J. Pharm. Sci. 1976, 65, 352–354. [Google Scholar] [CrossRef]
  163. Bogusz, M.J.; Maier, R.D.; Schäfer, A.T.; Erkens, M. Honey with Psilocybe mushrooms: A revival of a very old preparation on the drug market? Int. J. Legal Med. 1998, 111, 147–150. [Google Scholar] [CrossRef]
  164. Salvaña, F.R. Morphological and Histochemical Characterization of Callus from Leaf Explant of Tagetes lucida Cav. (Asteraceae). JNBR 2019, 8, 172–178. [Google Scholar]
  165. Esquivel-Gutiérrez, E.R.; Alcaraz-Meléndez, L.; Hernández-Herrera, R.; Torres, A.; Rodríguez-Jaramillo, C. Effects of damiana (Turnera diffusa; var. diffusa and var. aphrodisiaca) on diabetic rats. Acta Univ. 2018, 28, 84–92. [Google Scholar] [CrossRef]
  166. Dayton, W.A. Important Western Browse Plants; Miscellaneous Publication, 101; U.S. Department of Agriculture: Washington, DC, USA, 1931; Volume 214, p. 768.
Figure 1. Developmental defects and the mechanisms of teratogenicity of the main compounds identified in Mexican plants. (a) In the upper part, this fragment of the Florentino codex shows the importance of the role that plants played in the pre-Hispanic Mexican culture (a reflection of the current one). Hallucinogenic plants, from top: tlapatl, nanacatl, peyotl, and tolo (bottom) used by the ancient indigenous people to stimulate the nervous system, for ritual or medicinal purposes as in love sickness [129]. (b) Four of the following teratogenic plants most used by the Mexican population as medicine or food are depicted: Astragalus mollissimus [130]; Artemisia annua [131]; Silybum marianum [132], and Manihot esculenta [133]. At the bottom of the fragment, we find the responsible compound, the part of the plant in which the compound predominates, the proposed mechanisms of teratogenicity, and the observed teratogenic effects. (c) A 12.5 GD mouse embryo is shown inside its amniotic sac to represent the teratogenic mechanisms identified in Mexican plants that can affect its development. Although the exact mechanisms have not been fully clarified, the authors suspect that the main mechanisms in the observed teratogenic effect are as follows: oxidative stress; ischemia; enzymatic inhibition; alteration in levels of estrogens; cytotoxicity; apoptosis; interference with cellular mitosis; restricted fetal movements, among others. It is noteworthy that such alterations can be produced not only by a single mechanism, but also by the interaction of several of these.
Figure 1. Developmental defects and the mechanisms of teratogenicity of the main compounds identified in Mexican plants. (a) In the upper part, this fragment of the Florentino codex shows the importance of the role that plants played in the pre-Hispanic Mexican culture (a reflection of the current one). Hallucinogenic plants, from top: tlapatl, nanacatl, peyotl, and tolo (bottom) used by the ancient indigenous people to stimulate the nervous system, for ritual or medicinal purposes as in love sickness [129]. (b) Four of the following teratogenic plants most used by the Mexican population as medicine or food are depicted: Astragalus mollissimus [130]; Artemisia annua [131]; Silybum marianum [132], and Manihot esculenta [133]. At the bottom of the fragment, we find the responsible compound, the part of the plant in which the compound predominates, the proposed mechanisms of teratogenicity, and the observed teratogenic effects. (c) A 12.5 GD mouse embryo is shown inside its amniotic sac to represent the teratogenic mechanisms identified in Mexican plants that can affect its development. Although the exact mechanisms have not been fully clarified, the authors suspect that the main mechanisms in the observed teratogenic effect are as follows: oxidative stress; ischemia; enzymatic inhibition; alteration in levels of estrogens; cytotoxicity; apoptosis; interference with cellular mitosis; restricted fetal movements, among others. It is noteworthy that such alterations can be produced not only by a single mechanism, but also by the interaction of several of these.
Plants 11 01675 g001
Figure 2. Graphic summary of the most relevant data obtained in the documentary research. (a) Abundance of the families of compounds identified in the teratogenic plants analyzed; (b) percentages of the main animal species (models) used to evaluate the teratogenicity of plants in the collected studies; (c) main routes of administration utilized in the evaluation of teratogenicity in the studies consulted, and; (d) distribution of identified teratogenic plants, native to or introduced from other countries.
Figure 2. Graphic summary of the most relevant data obtained in the documentary research. (a) Abundance of the families of compounds identified in the teratogenic plants analyzed; (b) percentages of the main animal species (models) used to evaluate the teratogenicity of plants in the collected studies; (c) main routes of administration utilized in the evaluation of teratogenicity in the studies consulted, and; (d) distribution of identified teratogenic plants, native to or introduced from other countries.
Plants 11 01675 g002
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Chamorro-Cevallos, G.; Mojica-Villegas, M.A.; García-Martínez, Y.; Pérez-Gutiérrez, S.; Madrigal-Santillán, E.; Vargas-Mendoza, N.; Morales-González, J.A.; Cristóbal-Luna, J.M. A Complete Review of Mexican Plants with Teratogenic Effects. Plants 2022, 11, 1675. https://doi.org/10.3390/plants11131675

AMA Style

Chamorro-Cevallos G, Mojica-Villegas MA, García-Martínez Y, Pérez-Gutiérrez S, Madrigal-Santillán E, Vargas-Mendoza N, Morales-González JA, Cristóbal-Luna JM. A Complete Review of Mexican Plants with Teratogenic Effects. Plants. 2022; 11(13):1675. https://doi.org/10.3390/plants11131675

Chicago/Turabian Style

Chamorro-Cevallos, Germán, María Angélica Mojica-Villegas, Yuliana García-Martínez, Salud Pérez-Gutiérrez, Eduardo Madrigal-Santillán, Nancy Vargas-Mendoza, José A. Morales-González, and José Melesio Cristóbal-Luna. 2022. "A Complete Review of Mexican Plants with Teratogenic Effects" Plants 11, no. 13: 1675. https://doi.org/10.3390/plants11131675

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop